Full Press Release Details
to Present at the Susquehanna Financial Group's Second Annual Beijing Management
September 1, 2008 --- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused
biotech company in China, announced today that Mr. Weidong Yin, Chairman,
President and CEO, is scheduled to present at the Susquehanna Financial Group's
Second Annual Beijing Management Summit Conference, at Grant Hyatt Beijing Hotel
in Beijing, China. Sinovac's presentation is scheduled for Thursday, September
Biotech Ltd. is a China-based biopharmaceutical company that focuses on the
research, development, manufacture and commercialization of vaccines that
protect against human infectious diseases. Sinovac's commercialized vaccines
include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu
(influenza) and PanfluTM (H5N1).
Sinovac is currently developing Universal Pandemic Influenza vaccine and
Japanese encephalitis vaccine. Additional information about Sinovac is available
on its website, http://www.sinovac.com
. To be added to our distribution list, please email: info@sinovac.com.
announcement contains forward-looking statements. These statements are made
under the "safe harbor" provisions of the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be identified by words
or phrases such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements. Among other things, the
business outlook and quotations from management in this press release contain
forward-looking statements. Statements that are not historical facts, including
statements about Sinovac's beliefs and expectations, are forward-looking
statements. Forward-looking statements involve inherent risks and uncertainties.
A number of important factors could cause actual results to differ materially
from those contained in any forward-looking statement. Sinovac does not
undertake any obligation to update any forward-looking statement, except as
required under applicable law.
information, please contact:
Sinovac Biotech Ltd.
Tel: +86-10-8289-9871
Fax: +86-10-6296-6910
Email: info@sinovac.com
Stephanie Carrington
Tel: +1-646-536-7017
Email: scarrington@theruthgroup.com
Tel: +1-646-536-7033
Email: jmccargo@theruthgroup.com